S100A16 and cervical carcinoma: By analyzing the differences in S100A16 expression between tumor tissues and normal tissues in the TCGA datasets, we found that S100A16 expression was significantly increased in tumor tissue samples, and cervical cancer patients with high S100A16 expression had more rapid disease progression and shorter survival time.